Epidemiological correlates among women with Polycystic ovary syndrome in South India

Similar documents
Awareness of PCOS (polycystic ovarian syndrome) in adolescent and young girls

Comparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index

Risk of Developing Polycystic Ovarian Syndrome- Adolescent Girls

Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?

Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population

Obstretics and Gynaecology. Nikita M. Singh A, Deepak Kamat B, Parth Patel A, Tupe N.B C

SCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY

Manipal & Apollo Spectra Hospital. Special Interest:Laparoscopy & Bariatric Surgery

JMSCR Vol 05 Issue 04 Page April 2017

Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria

THYROID PROFILE IN POLYCYSTIC OVARIAN SYNDROME Sudhanshu Sekhara Nanda 1, Subhalaxmi Dash 2, Ashok Behera 3, Bharati Mishra 4

Pregnancy outcome in women with polycystic ovary syndrome

New PCOS guidelines: What s relevant to general practice

METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

3. Metformin therapy for PCOS

Scope. Update and expansion of Evidence-based guideline for the assessment and management of PCOS. Clinical context

X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

A study on the clinical, biochemical and hormonal profile of polycystic ovary syndrome patients attending tertiary care hospital

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Prevalence of Polycystic Ovary Syndrome and its Associated Risk Factors among Adolescent and Young Girls in Ahmedabad Region

WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED

Psychological impact of Polycystic Ovary Syndrome (PCOS)

Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)

UNDERSTANDING PCOS AND ITS DIAGNOSIS

JMSCR Vol 07 Issue 01 Page January 2019

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Rotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

PCOS and Obesity DUB is better treated by OCPs

ARTICLE. Primary Amenorrhea as a Manifestation of Polycystic Ovarian Syndrome in Adolescents

The Effect of Vitamin D Replacement Therapy on Serum Leptin and Follicular Growth Pattern in Women with Clomiphene Citrate Resistant Polycystic Ovary

Awareness of Polycystic Ovarian Disease among Females of Age Group Years

COMPARATIVE STUDY OF PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME IN RURAL AND URBAN POPULATION

The study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi

Cam type Femoroacetabular Impingement associated with Marker for Hyperandrogenism in Women

CORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2

Structured teaching programme on knowledge about polycystic ovarian syndrome among adolescent girls

Clinical Profile Polycystic Ovarian Syndrome Cases

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Overview of Reproductive Endocrinology

Prevalence and hormonal profile of polycystic ovary syndrome in young Kashmiri women presenting with hirsutism: A hospital based study

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

ASSOCIATION OF ANXIETY DISORDER IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME Sumbul Sohail 1, Rubina Salahuddin 1, Shabnum Nadeem 1

ASSOCIATION OF INSULIN RESISTANCE AND SERUM 25 OH VITAMIN-D IN INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Secretors Frequency and H-Substance Level in Polycystic Ovary Syndrome Patients and in Apparently Healthy Controls

JMSCR Vol 05 Issue 05 Page May 2017

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS)

European Journal of Endocrinology (2006) ISSN

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

A STUDY OF CLINICAL PARAMETERS IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME Soumya Ranjan Panda 1, K. Durgavati 2, Santhosh Kumar Sahu 3

International Journal of Health Sciences and Research ISSN:

International Academy of Engineering and Medical Research, 2018 Volume-3, Issue-1 Published Online January 2018 in IAEMR (

ROLE OF METFORMIN IN POLYCYSTIC OVARIAN SYNDROME

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?

IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS

Polycystic Ovary Syndrome

Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study

Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Polycystic Ovary Syndrome (PCOS):

Addressing Practice Gaps in PCOS

PCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

Original Investigation. 94 Endocrine Oncology and Metabolism. Jovanovska et al

Polycystic Ovary Syndrome

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

Prevalence of Polycystic Ovarian Syndrome among Female Students: A Cross-Sectional Study

Gynecology & Reproductive Health

Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria

CLINICAL, BIOCHEMICAL AND ULTRASONOGRAPHIC FEATURES OF INFERTILE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME

Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery

Estimation of serum 25 hydroxy vitamin D level and its correlation with metabolic and endocrine dysregulation in women with PCOS

Polycystic ovary syndrome (PCOS) Polycystic ovary syndrome: Why are women at increased risk of type 2 diabetes? Article.

Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners. M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017

Pattern of dermatologic manifestations in polycystic ovarian disease cases from a tertiary care hospital

PCOS guidelines: What s relevant to general practice

Update on Polycystic Ovary Syndrome What Dermatology Nurses and Nurse Practitioners Need to Know

Diagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome

Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)

Original Research Article

Metfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study

Research Article. Ramanand SJ 1, Raparti GT 2 *, Halasawadekar NR 1, Ramanand JB 3, Kumbhar AV 1, Shah RD 1

Fertility problems in women with polycystic ovary syndrome

Assisted Reproductive. Technologies: Present and. Future

Anuja Dokras, MD., PhD. Professor Obstetrics and Gynecology Director PENN PCOS Center University of Pennsylvania, USA.

Clinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS

An Evaluation of Carotid Artery Intimal Medial Thickness and Insulin Resistance in Women with Polycystic Ovarian Syndrome

IMPROVING FITNESS AND WELL-BEING IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME THE NEAT WAY

New technology and criteria for PCOS and PCOM

Impact of Obesity on Ovulatory Functions in Polycystic Ovarian Syndrome

Transcription:

ISSN: 2347-3215 Volume 2 Number 9 (September-2014) pp. 181-186 www.ijcrar.com Epidemiological correlates among women with Polycystic ovary syndrome in South India Pratik Kumar Chatterjee 1, P.Prasanna Mithra 2 *, Rahul Pal 3, Poulomi Chatterjee 4, B.Unnikrishnan 2, N.A.Vinodini 1, Aparna Tripathi 5, V.B.Suman 1, Anish Singhal 1 and Sheila R. Pai1 1 Department of Physiology, 2 Department of Community Medicine, 3 MBBS Student, Kasturba Medical College (KMC), Mangalore, Manipal University (MU), Karnataka, India 4 Dietician, formerly attached to Manipal Ecron Acu-Nova KH Clinical Research Centre, Manipal, Karnataka, India 5 Department of Physiology, Melaka Manipal Medical College (MMMC), Manipal University (MU), Manipal, Karnataka, India Corresponding author KEYWORDS Polycystic Ovary Syndrome, Blood group, Diabetes, BMI Introduction A B S T R A C T The present study aimed to find out the epidemiological correlates among women with PCOS in South India. 100 patients diagnosed with PCOS, between (18-40) years, were selected. A standard PCOS questionnaire was given & relevant data was collected. Patients were grouped according to their blood groups along with their age & BMI. Diabetes & family history were also considered (p 0.05 significant). In this study showed that, majority of the females diagnosed of PCOS were between (21-30) years with an increasing trend being observed between BMI & ageing. Our data revealed that among the females belonging to O+ blood group, 57.7% (p 0.05) were overweight/obese (taken together). Also, 40% of the patients included in the study group were diagnosed cases of diabetes & 28% of females had family history of PCOS. Therefore the present study suggests that majority of O+ females diagnosed of PCOS, were obese/overweight. Also an increasing trend of BMI with ageing was observed. Diabetes & family history of PCOS were additive factors. So, early screening of O+ females in South India, between the age group of (21-30) years could be useful for early diagnosis of PCOS, which might help for better management & prevention of further complications. Polycystic ovary syndrome (PCOS), a complex heterogeneous endocrine disorder (Legro RS, 2002) is the most common cause of anovulation in women even with normal levels of serum follicle stimulating hormone (FSH) & estradiol (Bushra et al., 2013). This condition was first described in the year 181

1935, by American gynecologists Irving F.Stein, Sr. & Michael L. Leventhal & hence was originally named after them as Stein-Leventhal Syndrome (Azziz, 2006). PCOS - a marker of metabolic syndrome has been known to be associated with various conditions like, ovulatory dysfunctions, type II diabetes, hypertension, cardiovascular diseases, etc.,(aziz, 2006). There is emerging evidence that women with PCOS have an increased risk of being overweight & obese and also have a higher tendency of longitudinal weight gain (Moran, 2013). Review of Literature Polycystic ovary syndrome (PCOS) is one of the most common syndromes in women during their reproductive age. Though the most common features usually include excessive weight gain, oligomenorrhea/amenorrhea, increased triglyceride & insulin levels in the blood, acne, hirsutism, hypermenorrhea, etc., it is also associated with menstrual disorders & infertility usually occurring due to chronic anovulation (Teede et al., 2010; Christine et al., 2006). Though the exact cause of PCOS is unknown, evidence suggests that it s a genetic disease (Diedrich et al., 2011). A recent study has proposed that there is an increased prevalence of overweight/ obesity in women with PCOS. Also, a bidirectional interaction between PCOS & weight exists, i.e., PCOS causing weight gain and weight gain leading to an increase in the prevalence & severity of PCOS (Moran et al., 2013). Body mass index (BMI), also known as Quetelet index, is a measure of relative weight based on an individual's mass & height. It was formulated by the Belgian polymath Adolphe Quetelet, between1830 and 1850. BMI is therefore defined as the individual's body mass divided by the square of his/her height, with the unit universally being given in kg/m2 (Eknoyan et al., 2007). It s well known that PCOS is independently associated with BMI. Though this might be due to a higher energy intake sedentary lifestyle observed in females suffering from PCOS, research has shown that elevated adiposity in PCOS is most probably not related to adverse lifestyle behaviours (Moran et al., 2013). It is possible that women with PCOS have a greater tendency to elevated adiposity due to intrinsic hormonal aberrations, including insulin resistance and hyperandrogenism (Pasquali et al., 2006). Till date, no relevant study has been done to find out whether any link exists between PCOS & blood group with various other associated factors, like BMI, age-group, diabetes & family history. So, the present study was designed to find out the epidemiological correlates among women with PCOS, between the age-group of (18-40) years, in South India. Experimental Study design & setting: This is a hospital based cross sectional study which is, being conducted for a duration of one year & is based on the data obtained from the patients of Kasturba Medical College Hospitals & Government Lady Goshen Hospital, Mangalore, Karnataka, India. The Human Institutional Ethics Committee of Kasturba Medical College (KMC), Mangalore, Manipal University (MU), Karnataka, India approved the study protocol. Each patient was explained the purpose, procedures & confidentiality of this study at orientation & then a written informed consent was obtained from each participant. Inclusion criteria: The study incorporated patients between the age group of (18-40) years, diagnosed of PCOS. 182

Exclusion criteria: Patients diagnosed of suffering from any chronic illnesses (except diabetes mellitus) & those who had submitted incomplete questionnaire data were not included in the study (ten women were excluded on this basis, leaving 100 patients eligible for the study). Method of study: The study involved 100 patients, diagnosed with PCOS, between the age group of (18-40) years, from our hospitals. A PCOS questionnaire was handed over to the patients & data was recorded in the proforma for each patient (PCOS Questionnaire: info@nutrition specialists.com, The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group2003). Patients were grouped according to their blood groups along with their age & BMI. Overweight & obesity defined as per the World Health Organization/WHO 2000 criteria, i.e., overweight/pre-obese when BMI= (25-30) kg/m2 & obese when BMI 30 kg/m2 (Moran et al., 2013). Diabetes & family history were also considered. A correlative analysis of the data was then be made accordingly. Statistical analysis: Parameters were analyzed using Chi-square test. p 0.05 was considered as significant. Age group (years) BMI classification Table.1 Demographic & morbidity profile of the study population (n=100) Characteristics <20 36 (36.0) (21-30) 42 (42.0) (31-40) 22 (22.0) Normal 52 (52.0) Overweight 32 (32.0) Obese 16 (16.0) Table.2 Association between BMI & blood groups among the subjects (n=100) Characteristics Blood group Normal BMI classification Overweight & Obese Total A+ 08 (57.1) 06 (42.9) 14 (12.5) B+ 14 (53.8) 12 (46.2) 26 (25.0) AB+ 08 (100) 00 (00.0) 08 (52.0) O+ 22 (42.3) 30 (57.7)* 52 (52.0) Total 52 (52.0) 48 (48.0) 100 * p 0.05 significant p value 0.017* 183

Table.3 Association between BMI and age groups among the subjects (n=100) Characteristics Age group (years) Normal BMI classification Overweight & Obese Total <20 58.3 41.7 36.0 (21-30) 50.0 50.0 42.0 (31-40) 45.5 54.5 22.0 Total 52 (52.0) 48 (48.0) 100 p value 0.598 Result and Discussion Table 1 depicts an outline of the demographic & morbidity profile of the study population, which included a total of hundred patients (n=100), diagnosed of PCOS. Though majority (42%) of them were in the age-group of (21-30) years, about 48% of the patients included in this study population were found to be in the overweight/obese category, taken together. An association between BMI & blood groups among the patients (n=100) is represented in Table 2. As observed, overall 48% of the females diagnosed of PCOS were overweight/obese but the percentage of overweight & obese (taken together) was highest (57.7%) among the patients belonging to O+ blood group. The difference across the groups was found to be statistically significant (p 0.05). Table 3 describes the association between BMI & age groups among the subjects (n=100). Majority (42%) of them were in the agegroup of (21-30) years. Though about 50% of the patients in this group were overweight/obese (taken together), the difference across the groups was not found to be statistically significant. Moreover, an increasing trend of BMI with ageing was observed. Our data also revealed that 40% of the patients included in the study group were diagnosed cases of diabetes & 28% of the females had family history of PCOS. The prevalence of different blood types among a group of persons studied showed that approximately 47% & 41% of the people were from O & A blood groups respectively followed by 9% from B. Only 3% of them belonged to AB blood group. About 85% of all white people & 95% of American blacks were Rh+ (Gyton & Hall, 2006). But, literature reveals that about 39% of the Indian population belongs to blood group B, followed by blood group O (31%) & A (21%). Only about 9.0%of the Indian population belongs to blood group AB. About 95% of these people are Rh+ & 5% are Rh-. Studies have shown that that blood group substances play a major role in the causation of diseases (Ghai CL, 2013) Polycystic ovary syndrome (PCOS) affects approximately (5-10) % of the Indian female population (Nidhi et al., 2011). Though previous report has shown that PCOS may occur at an younger age in girls who develop early pubarche & thelarche (Bronstein et al., 2011), our study revealed that majority of the females diagnosed of PCOS were in the age-group of (21-30) years & a large number of them were found to be in 184

overweight/obese. Study conducted has shown that the prevalence rates of PCOS are rising in countries, where obesity & type II diabetes are more common (Allahbadia et al., 2008). It is well known that in India, females with blood group O+ have the highest risk of developing PCOS, followed by women of blood group B+ & Rh negative individuals didn t show any association with PCOS (Rahul et al., 2014). Our data are also in accordance with previous studies which show that the among the PCOS patients, percentage of overweight & obese was highest in O+ blood group. It is well established that there is an increase in body weight & BMI with age & decline with advanced age, i.e., after 50 years (Kapoor, 2002). About (35-65)% of PCOS patients are obese, i.e., obesity, overweight & elevated BMI are the most common associated clinical features of this condition (Al. Agemi et al., 2004). The present findings reveal an increasing trend of BMI with ageing with diabetes & family history of PCOS being additive factors. References Al. Agemi M, Omv FE, Omu AE. The effect of obesity on the outcome of infertility management in women with Polycystic Ovary Syndrome. Archieves of Gynecology & Obstretics. 2004; 270: 209-210 Allahbadia GN, Merchant R. Polycystic Ovary Syndrome in the Indian Subcontinent. Seminars in Reproductive Medicine. 2008; 26(1): 22-34 Azziz R. Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature". Journal of Clinical Endocrinology & Metabolism. 2006;91(3):781-85 Aziz R. How prevalent is metabolic syndrome in women with polycystic ovary syndrome? National Clinical Practice Endocrinology Metabolism. 2006; 22: 465-470 Bronstein J, Tawelekars, Liv Y, PaweKzak M, David R, Shah B. Age of onset of Polycystic Ovary Syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol. 2011; 24(1): 15-20 BushraFiza, RatiMathur, PushpendraSaraswat. PCOS - correlation amongst Serum levels of Testosterone, Anti-Mullerian Hormone & Other Sex Hormones. International Journal of Biological & Medical Research. 2013; 4(3): 3290-3293 Christine Cortet Rudelli, Didier Dewailly. Diagnosis of Hyperandrogenism in Female Adolescents.Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health.am 2006 Diedrich K, Bouchard P, Dominguez F, Matzuk M, Franks S. HamamahS. et al.. Contemporary genetic technologies and female reproduction.human Reproduction Update. 2011; 17 (6): 829-47 Eknoyan, Garabed (2007). "Adolphe Quetelet (1796 1874) - the average man and indices of obesity". Nephrology Dialysis Transplantation 23 (1): 47-51. Ghai CL. Textbook of practical physiology. 8thed. New Delhi: Jaypee Brothers. 2013; 107-108 Gyton & Hall. Textbook of Medical Physiology. 11thed. Philadelphia, Pennsylvania: Saunders. 2006; 452-453 Kapoor S & Tyagi S. Fatness, fat patterns & changing body dimensions with age in adult males of a high altitude population, in Science of Man in the Service of Man, M K Bhasin & S.L. Malik, Eds., 2002; 8: 129-136 185

Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertility and Sterility. 2002; 78(3): 569-76 Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The Contribution of Diet, Physical Activity and Sedentary Behaviour to Body Mass Index in Women With and Without Polycystic Ovary Syndrome. Hum Reprod. 2013; 28(8): 2276-2283 Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011; 24(4): 223-27 Pasquali R, Gambineri A, Pagotto U. The Impact of Obesity on Reproduction in Women with Polycystic Ovary Syndrome. BJOG: An International Journal of Obstetrics and Gynaecology. 2006; 113(10):1148-59 PCOS Questionnaire: info@nutrition specialists.com Rahul P, Pratik K C, Poulomi C, Vinodini NA, Prasanna M, Sourjya B, Suman VB, Sheila R P. Polycystic Ovary Syndrome, Blood Group & Diet: A Correlative Study In South Indian Females. International Journal of Medical Research & Health Sciences (IJMRHS). 2014; 3(3): 604-609 Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. "revised 2003609 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome(pcos). Human Reproduction. 2003; 19 (1): 41-47 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex conditions with psychological, reproductive and metabolic manifestations that impact on health across the lifespan. BMC Medicine 2010; 8: 41 186